Stifel Financial Corp Novo Cure LTD Transaction History

Stifel Financial Corp

$93.2 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$63.98 - $85.37 $30,326 - $40,465	-474 Reduced 6.76%	6,537 $479,000
Q3 2022 Nov 14, 2022	SELL	$67.99 - $89.57 $12,374 - $16,301	-182 Reduced 2.53%	7,011 $532,000
Q2 2022 Aug 15, 2022	SELL	$56.6 - $89.9 $5,377 - $8,540	-95 Reduced 1.3%	7,193 $499,000
Q1 2022 May 13, 2022	SELL	$60.15 - $84.52 $48,541 - $68,207	-807 Reduced 9.97%	7,288 $604,000
Q4 2021 Feb 14, 2022	SELL	$75.08 - $121.99 $148,958 - $242,028	-1,984 Reduced 19.68%	8,095 $608,000
Q3 2021 Nov 15, 2021	BUY	$116.17 - $194.55 $134,292 - $224,899	1,156 Added 12.96%	10,079 $1.17 Million
Q2 2021 Aug 13, 2021	BUY	$130.4 - $225.58 $111,883 - $193,547	858 Added 10.64%	8,923 $1.98 Million
Q1 2021 May 14, 2021	SELL	$124.11 - $190.17 $245,986 - $376,916	-1,982 Reduced 19.73%	8,065 $1.07 Million
Q4 2020 Feb 12, 2021	BUY	$112.16 - $174.14 $138,405 - $214,888	1,234 Added 14.0%	10,047 $1.74 Million
Q3 2020 Nov 16, 2020	SELL	$58.05 - $111.31 $21,768 - $41,741	-375 Reduced 4.08%	8,813 $981,000
Q2 2020 Aug 14, 2020	BUY	$57.2 - $74.41 $62,576 - $81,404	1,094 Added 13.52%	9,188 $545,000
Q1 2020 May 14, 2020	BUY	$57.05 - $95.75 $188,778 - $316,836	3,309 Added 69.15%	8,094 $543,000
Q4 2019 Feb 13, 2020	SELL	$68.3 - $93.8 $932,773 - $1.28 Million	-13,657 Reduced 74.05%	4,785 $405,000
Q3 2019 Nov 13, 2019	SELL	$61.86 - $97.8 $108,873 - $172,128	-1,760 Reduced 8.71%	18,442 $1.38 Million
Q2 2019 Aug 14, 2019	SELL	$42.22 - $63.23 $380,402 - $569,702	-9,010 Reduced 30.84%	20,202 $1.28 Million
Q1 2019 May 14, 2019	SELL	$31.96 - $56.12 $85,812 - $150,682	-2,685 Reduced 8.42%	29,212 $1.41 Million
Q3 2018 Nov 13, 2018	SELL	$32.0 - $52.4 $160,000 - $262,000	-5,000 Reduced 13.55%	31,897 $1.67 Million
Q2 2018 Aug 14, 2018	SELL	$19.85 - $32.0 $340,824 - $549,440	-17,170 Reduced 31.76%	36,897 $1.15 Million
Q1 2018 May 11, 2018	SELL	$19.3 - $23.65 $113,078 - $138,565	-5,859 Reduced 9.78%	54,067 $1.18 Million
Q4 2017 Feb 14, 2018	SELL	$16.3 - $21.9 $481,502 - $646,926	-29,540 Reduced 33.02%	59,926 $1.21 Million
Q3 2017 Nov 13, 2017	BUY	$18.05 - $21.75 $1.61 Million - $1.95 Million	89,466	89,466 $0

Others Institutions Holding NVCR

# of Institutions

262

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

Black Rock Inc. New York, NY

12.1M
Shares

$215 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.8M
Shares

$210 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

7.92M
Shares

$140 Million
0.02% of portfolio
Capital World Investors Los Angeles, CA

4.31M
Shares

$76.4 Million
0.01% of portfolio
Nordwand Advisors, LLC Radnor, PA

3.03M
Shares

$53.7 Million
12.67% of portfolio

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.86B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Account